Exploring the Validity of Available Markers and Indices in the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) in People with Type 2 Diabetes in Saudi Arabia

por Ajabnoor, Ghada M. A., Bahijri, Suhad M., Enani, Sumia Mohammad, Alsheikh, Lubna, Ahmed, Maimoona, Alhozali, Amani, Al-Shali, Khalid, Eldakhakhny, Basmah Medhat, Alamoudi, Aliaa A., Al-Ahmadi, Jawaher, Borai, Anwar, Al-Mowallad, Alaa Salem, Tuomilehto, Jaakko
Publicado 2023

Reported Benefits of Insulin Therapy for Better Glycemic Control in Type 2 Diabetic Patients—Is This Applicable in Saudi Patients?

por AlSaggaf, Wafaa, Asiri, Mohammed, Ajlan, Balgees, Afif, Alaa Bin, Khalil, Roaa, Salman, Anas Bin, Alghamdi, Ahmed, Bashawieh, Osama, Alamoudi, Atheer, Aljahdali, Abeer, Aljahdali, Nouf, Patwa, Hussam, Bakhaidar, Mohammed, Bahijri, Suhad M., Ahmed, Maimoona, Al-Shali, Khalid, Bokhari, Samia, Alhozali, Amani, Borai, Anwar, Ajabnoor, Ghada, Tuomilehto, Jaakko
Publicado 2016